Patrick Barry Mark
Impact in
- Nephrology top 0.1%
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
- Renal Diseases and Glomerulopathies
- Transplantation top 0.5%
- Renal Transplantation Outcomes and Treatments
Papers in
- Nephrology 110
- Chronic Kidney Disease and Diabetes 57
- Dialysis and Renal Disease Management 37
-
- Blood Pressure and Hypertension Studies 22
- Heart Failure Treatment and Management 15
- Co-authors
- Alan G. Jardine (59 shared papers)Henry J. Dargie (18 shared papers)Rajan Kantilal Patel (30 shared papers)Jennifer Susan Lees (55 shared papers)Sokratis Stoumpos (16 shared papers)Paul I. Welsh (28 shared papers)Naveed A. Sattar (23 shared papers)Giles Roditi (28 shared papers)
- Journals
- Nephrology Dialysis Transplantation (40 papers)Kidney International (17 papers)Clinical Kidney Journal (15 papers)The Lancet (12 papers)BMC Nephrology (10 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Patrick Barry Mark
323 papers receiving 12.4k citations
Patrick Barry Mark's Hit Papers
Peers
Comparison fields: 5 of 150
- Nephrology 3.3k
- Transplantation 552
- Cardiology and Cardiovascular Medicine 3.0k
- Endocrinology, Diabetes and Metabolism 2.0k
- Hematology 536
Countries citing papers authored by Patrick Barry Mark
This map shows the geographic impact of Patrick Barry Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Barry Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Barry Mark more than expected).
Fields of papers citing papers by Patrick Barry Mark
This network shows the impact of papers produced by Patrick Barry Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Barry Mark. The network helps show where Patrick Barry Mark may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Barry Mark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 346 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 519 |
| 2 | Chronic Kidney Disease and Coronary Artery Disease Hit paper breakdown → | 2019 | 503 |
| 3 | Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF) Hit paper breakdown → | 2020 | 345 |
| 4 | Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Hit paper breakdown → | 2019 | 339 |
| 5 | Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial Hit paper breakdown → | 2022 | 272 |
| 6 | 2007 | 266 | |
| 7 | Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study Hit paper breakdown → | 2022 | 235 |
| 8 | 2018 | 227 | |
| 9 | 2019 | 221 | |
| 10 | 2006 | 213 | |
| 11 | 2018 | 203 | |
| 12 | Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes Hit paper breakdown → | 2023 | 200 |
| 13 | Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association Hit paper breakdown → | 2023 | 189 |
| 14 | Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial Hit paper breakdown → | 2023 | 185 |
| 15 | 2005 | 184 | |
| 16 | 2019 | 179 | |
| 17 | 2017 | 177 | |
| 18 | 2020 | 174 | |
| 19 | 2004 | 162 | |
| 20 | 2014 | 161 |
About Patrick Barry Mark
Patrick Barry Mark is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Transplantation and Pulmonary and Respiratory Medicine, having authored 346 papers that have together received 12.8k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (57 papers), Dialysis and Renal Disease Management (37 papers), Diabetes Treatment and Management (29 papers), Renal Transplantation Outcomes and Treatments (23 papers), Blood Pressure and Hypertension Studies (22 papers), Renal and Vascular Pathologies (21 papers), Hormonal Regulation and Hypertension (16 papers) and Heart Failure Treatment and Management (15 papers). The work is most often cited by research in Nephrology (3.3k citations), Transplantation (552 citations), Cardiology and Cardiovascular Medicine (3.0k citations), Endocrinology, Diabetes and Metabolism (2.0k citations) and Hematology (536 citations). Patrick Barry Mark has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Alan G. Jardine, Henry J. Dargie, Rajan Kantilal Patel, Jennifer Susan Lees, Sokratis Stoumpos, Paul I. Welsh, Naveed A. Sattar, Giles Roditi, Tracey Steedman and Kevin G. Blyth. Their work appears in journals such as Nephrology Dialysis Transplantation, Kidney International, Clinical Kidney Journal, The Lancet and BMC Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.